{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:13:23Z","timestamp":1778764403710,"version":"3.51.4"},"reference-count":141,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2026,4,13]]},"DOI":"10.1080\/14656566.2026.2657996","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:36:12Z","timestamp":1775655372000},"page":"481-494","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Emerging approaches to difficult-to-manage axial spondyloarthritis"],"prefix":"10.1080","volume":"27","author":[{"given":"Jack Shi Jie","family":"Yuan-Dor\u00e9","sequence":"first","affiliation":[{"name":"Royal Free London NHS Foundation Trust","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Yin","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Haider","family":"Tahir","sequence":"additional","affiliation":[{"name":"Kings College London","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Bamford","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Tahir","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust","place":["London, UK"]},{"name":"University College London","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221035"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.01.035"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217344"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01329-3"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.10.002"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf120"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.63032\/KWAT7525"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-025-07626-2"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf641"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.70558"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003461"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.131124.dma"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.46497\/ArchRheumatol.2024.10567"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.290124.dtt"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105670"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212127"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-024-00684-z"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2024-12-3"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.03.013"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213654"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00776-6"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2605204"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.4"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000437077"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0067"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39841"},{"issue":"1","key":"e_1_3_4_29_1","first-page":"110","article-title":"Optimal concentration range of golimumab in patients with axial spondyloarthritis","volume":"36","author":"Mart\u00ednez-Feito A","year":"2018","unstructured":"Mart\u00ednez-Feito A, Plasencia-Rodriguez C, Navarro-Comp\u00e1n V, et al. Optimal concentration range of golimumab in patients with axial spondyloarthritis. Clin Exp Rheumatol. 2018;36(1):110\u2013114.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.94023"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201544"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001047"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1849-3"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222155"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2021.12.001"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0256-7"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06605-9"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223296"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0522"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf089"},{"issue":"25","key":"e_1_3_4_42_1","first-page":"00287","article-title":"Time to lift the moratorium on IL-23 inhibitors for axial psoriatic arthritis","volume":"2665","author":"Tonutti A","year":"2025","unstructured":"Tonutti A, Abacar K, Macleod T, et al. Time to lift the moratorium on IL-23 inhibitors for axial psoriatic arthritis. Lancet Rheumatol. 2025;S2665-9913(25):00287\u20135.","journal-title":"Lancet Rheumatol"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40728"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218808"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000657"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22999"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100503"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04621-5"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000388"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-004009"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000001023"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab242"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216143"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40185"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab019"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket433"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150648"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001225"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200319451"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32835a9414"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key371"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2019.19073"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205133"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-0920"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081048"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.671976"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39464"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.17666"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13271"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000283"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170094"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh595"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215589"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-222081"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004369"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep393"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-06018-6"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218669"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.5114\/reum\/185429"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa768"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead598"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03971-6"},{"key":"e_1_3_4_83_1","unstructured":"Pipeline | Moonlake TX Immunotherapeutics [Internet]. 2024 [cited 2026 Feb 9]. Available from: https:\/\/moonlaketx.com\/pipeline\/"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac522"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03412-8"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X251324429"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32463-2"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab758"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab543"},{"key":"e_1_3_4_90_1","unstructured":"Alfasigma SPA. A phase 3 randomized placebo-controlled double-blind parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthritis [Internet]. Report No.: NCT05785611. clinicaltrials.gov; 2025 [cited 2026 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05785611"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000525627"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213328"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30263-4"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30265-8"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00105-3"},{"key":"e_1_3_4_96_1","unstructured":"Janssen Research & Development LLC. A phase 4 multicenter randomized double-blind placebo-controlled study evaluating the efficacy and safety of guselkumab administered subcutaneously in bio-naive participants with active psoriatic arthritis axial disease [Internet]. Report No.: NCT04929210. clinicaltrials.gov; 2026 [cited 2026 Feb 17]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04929210"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes316"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/901679"},{"key":"e_1_3_4_99_1","unstructured":"Merck Sharp & Dohme LLC. A phase 2b randomized double-blind placebo-controlled study to evaluate the efficacy and safety of Tulisokibart in participants with radiographic axial spondyloarthritis (ankylosing spondylitis) [Internet]. Report No.: NCT07133633. clinicaltrials.gov; 2026 [cited 2026 Feb 9]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07133633"},{"key":"e_1_3_4_100_1","unstructured":"Spyre Therapeutics Inc. Phase 2 study to assess the efficacy and safety of SPY002-072 in adults with moderately to severely active Rheumatologic disease [Internet]. Report No.: NCT07148414. clinicaltrials.gov; 2026 [cited 2026 Feb 9]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07148414"},{"key":"e_1_3_4_101_1","unstructured":"Grey Wolf Therapeutics. A multi-part phase I&II study to evaluate the safety and tolerability of GRWD0715 in healthy human volunteers and participants with axial spondyloarthritis [Internet]. Report No.: NCT07047703. clinicaltrials.gov; 2026 [cited 2026 Feb 9]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07047703"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.873"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1712-y"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.513"},{"key":"e_1_3_4_105_1","unstructured":"Maksymowych W Lambert R \u015aliwinska-Sta\u0144czyk P et al. A phase 2 multicenter randomized double-blinded placebo-controlled parallel-group study to evaluate the efficacy and safety of a mitogen-activated protein kinase-activated protein kinase 2 (MK2) inhibitor in active ankylosing spondylitis. ACR meeting abstracts. American College of Rheumatology; 2024 [cited 2026 Feb 9]. Available from: https:\/\/acrabstracts.org\/abstract\/a-phase-2-multicenter-randomized-double-blinded-placebo-controlled-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-a-mitogen-activated-protein-kinase-activated-protein-kinase-2-mk2-i\/"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00099-7"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00427-7"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20014"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14584"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1283251"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103865"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.041025.eor"},{"issue":"9","key":"e_1_3_4_113_1","article-title":"Rotation or change of biologic after TNF blocker treatment failure for axial spondyloarthritis [abstract]","volume":"77","author":"Dalix E","year":"2025","unstructured":"Dalix E, Goupille P, Wendling D, et al. Rotation or change of biologic after TNF blocker treatment failure for axial spondyloarthritis [abstract]. Arthritis Rheumatol. 2025;77(suppl 9). https:\/\/acrabstracts.org\/abstract\/rotation-or-change-of-biologic-after-tnf-blocker-treatment-failure-for-axial-spondyloarthritis\/","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70212"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2604681"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220973"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-222020"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0066-2"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220249"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206807"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002256"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-023-00585-7"},{"key":"e_1_3_4_123_1","unstructured":"NG65: spondyloarthritis in over 16s: diagnosis and management [Internet]. NICE; 2017 [cited 2026 Feb 9]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng65"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkag005"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1745409"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2022.2140842"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.20336"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-11373-7"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23892"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24556"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2018-099943"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzaa086"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.02.069"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkae062"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13102-022-00397-2"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2499959"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02922-y"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192114195"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1372-3"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002663"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220596"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-019-0819-8"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25679"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2657996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:54:42Z","timestamp":1778763282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2026.2657996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,4,13]]}},"alternative-id":["10.1080\/14656566.2026.2657996"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2026.2657996","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}